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Abstract  23 
Interleukin 25 (IL-25) is a major 'alarmin' cytokine, capable of initiating and 24 
amplifying the type 2 immune response to helminth parasites. However its role in the 25 
later effector phase of clearing chronic infection remains unclear. The helminth 26 
Heligmosomoides polygyrus establishes long-term infections in susceptible C57BL/6 27 
mice, but is slowly expelled in BALB/c mice from day 14 onwards. We noted that IL-28 
25R (Il17rb)-deficient BALB/c mice were unable to expel parasites despite type 2 29 
immune activation comparable to the wild-type. We then established that in C57BL/6 30 
mice, IL-25 adminstered late in infection (days 14-17) drove immunity. Moreover 31 
when IL-25 and IL-4 were delivered to Rag1-deficient mice, the combination resulted 32 
in near complete expulsion of the parasite, even following administration of an anti-33 
CD90 antibody to deplete innate lymphoid cells (ILCs). Hence, effective anti-helminth 34 
immunity during chronic infection requires an innate effector cell population that is 35 
synergistically activated by the combination of IL-4Rα and IL-25R signaling. 36 
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Introduction 37 
Type-2 immunity is generated by the immune system in response to a range of 38 
environmental challenges from helminth worm parasites, ectoparasites and allergens 39 
(Hammad and Lambrecht, 2015, Harris and Loke, 2017). In the absence of any 40 
vaccines, gastrointestinal helminths continue to infect many hundreds of millions of 41 
people in less-affluent countries (Pullan et al., 2014). Type 2 immunity to parasites is 42 
critically dependent upon pathways driven through and co-ordinated by IL-4Rα 43 
signaling (Urban et al., 1998, Voehringer et al., 2006). IL-4Rα activation can result in 44 
a multitude of immune outcomes (Allen and Maizels, 2011, Patel et al., 2009), 45 
however, few other components of immunity have been defined as either necessary or 46 
sufficient for worm expulsion.  47 
The epithelial-derived ‘alarmin’ cytokines, including IL-25, IL-33 and TSLP elicit and 48 
amplify type 2 immunity through the action of group 2 innate lymphoid cells (ILC2s) 49 
(Koyasu and Moro, 2012, McKenzie et al., 2014, Ziegler and Artis, 2010). There are 50 
however important distinctions in both the modes of action of these cytokines, and in 51 
the cells, bearing receptors for each mediator. Thus, ligation of the heterodimeric TSLP 52 
receptor stimulates dendritic cells to favor a Th2 cell response, and activates innate 53 
type 2 population (Ito et al., 2005, Siracusa et al., 2011, Soumelis et al., 2002, Ziegler 54 
et al., 2013); IL-25 receptors (heterodimers of IL-17RA and IL-17RB chains) are 55 
expressed on a number of tissues and cell types and increase IL-4 expression by Th2 56 
cells (Angkasekwinai et al., 2007); and receptors for IL-33 (an Interleukin-1-like 57 
cytokine that signals via the IL-1 receptor-related protein ST2) are broadly expressed 58 
in many tissues and induce type 2 cytokine expression by ILC2s and T cells (Cayrol 59 
and Girard, 2018, Schmitz et al., 2005).  60 
Although IL-25 (originally termed IL-17E) shares structural similarity with other IL-17 61 
family members it acts in an opposing manner to IL-17A, by inducing a suite of Type 2 62 
responses (Kim et al., 2002, Pan et al., 2001) and preventing IL-17A-dependent 63 
autoimmune disease (Kleinschek et al., 2007). IL-25 is highly expressed within the tuft 64 
cells of the gastrointestinal tract (Gerbe et al., 2016, von Moltke et al., 2016), but is 65 
also produced by a range of core immune populations, including T cells and 66 
granulocytes. IL-25 plays an important role in inducing allergic inflammation (Barlow 67 
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et al., 2012, Petersen et al., 2014) and in driving tissue remodeling and fibrosis 68 
(Gregory et al., 2013, Hams et al., 2014)).  69 
A number of laboratories have reported that IL-25 is induced by infection with, and 70 
required for immunity to, the nematode Nippostrongylus brasiliensis, a rat parasite that 71 
briefly infects immune-competent mice (Fallon et al., 2006, Fort et al., 2001, Hurst et 72 
al., 2002, Zhao et al., 2010), as well as the nematodes Heligmosomoides polygyrus 73 
(Pei et al., 2016), Trichuris muris (Owyang et al., 2006) and Trichinella spiralis 74 
(Angkasekwinai et al., 2013). IL-25 may be more important in activation of innate than 75 
adaptive immunity, as IL-25-deficient mice mounted normal Th2 responses following 76 
N. brasiliensis infection (Mearns et al., 2014), while ILCs grown in vitro in the 77 
presence of IL-25 and IL-33 were able to stimulate expulsion of this parasite upon 78 
adoptive transfer to susceptible IL-25R-deficient (Il17rb-/-) mice (Neill et al., 2010).  79 
Due to the rapid nature of expulsion of N. brasiliensis, it is difficult to separate the role 80 
of IL-25 in the initial drive towards Th2 responsiveness and any subsequent activation 81 
of effector mechanisms. We therefore studied chronic infection with the nematode H. 82 
polygyrus, in which induction over the first 7-10 days can be analysed separately from 83 
the subsequent expulsion phase: in so doing, we report that IL-25 is in fact redundant 84 
for Th2 initiation, but acts during the later phase of effector expulsion against this 85 
helminth parasite. Such a downstream role is consistent with recent reports 86 
demonstrating a role for IL-25 in protective immunity to a secondary infection with H. 87 
polygyrus, following drug clearance of a primary infection (Pei, et al., 2016), or 88 
vaccination with parasite secreted antigens (Hewitson et al., 2015). More broadly, a 89 
critical role for IL-25 in a late-stage immune response is also evident in airway 90 
inflammation models, in which it plays a central role in stimulating inflammatory 91 
myeloid cells and promoting airway remodeling (Gregory, et al., 2013, Petersen et al., 92 
2012), or in driving allergic reactions to airway challenge in previously sensitized mice 93 
(Ballantyne et al., 2007, Cayrol and Girard, 2018). 94 
95 
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Results 96 
IL-25R is redundant for generation of adaptive type-2 responses following 97 
chronic helminth infection 98 
To investigate the role of IL-25R in generation of innate and adaptive type-2 responses 99 
following chronic parasite infection, we used mice deficient in the IL-25-specific 100 
receptor subunit Il17rb (Neill, et al., 2010). We evaluated the outcome of H. polygyrus 101 
infection in mice of the BALB/c genetic background, which are partially resistant and 102 
able to expel most adult worms by day 28 following infection (Filbey et al., 2014, 103 
Reynolds et al., 2014). At day 14 post-infection, shortly after adult worms have 104 
matured, Il17rb-/- mice exhibited significantly increased egg production (Fig. 1 A) but 105 
equivalent adult worm burdens (Fig. 1 B) to the IL-25-sufficient wild-type BALB/c. 106 
By day 28, the Il17rb–/– genotype was unable to reduce adult worm or egg burdens 107 
(Fig. 1 C, D). 108 
A number of cell types have been shown to express IL-25R and contribute to type-2 109 
inflammation, including ILCs and multi-potent progenitor type 2 cells (Huang et al., 110 
2015, Saenz et al., 2013), myeloid cells (Dolgachev et al., 2009, Petersen, et al., 2012), 111 
NKT cells (Stock et al., 2009, Terashima et al., 2008) and eosinophils (Kim, et al., 112 
2002). We first took the approach of analysing individual cell types within BALB/c 113 
and Il17rb–/– mice and found equivalent increases in total and IL-13-expressing ILCs in 114 
the MLN (Fig. 1 E, F) in both strains at day 14 post-infection, and similar increases in 115 
the number of Siglec-F-CD11b+Ly6C/G+ myeloid cells in the peritoneal lavage (PL) 116 
(Fig. 1 G). However, we noted significantly reduced proportions of Siglec-F+ 117 
eosinophils and resistin-like molecule (RELM)-α+ macrophages in the PL of Il17rb–/– 118 
mice at steady-state and during the acute phase of infection (day 7). From day 14 when 119 
parasites are in the intestinal lumen and infection enters chronicity, proportions of both 120 
cell types increased closer to levels found in wild-type mice (Fig. 1 H, I). We also 121 
evaluated typical type-2 cytokine production (IL-4, IL-5 and IL-13) in response to 122 
restimulation with parasite antigen (HES); this was found to be equivalent in 123 
H.polygyrus-infected BALB/c and Il17rb–/– mice (Fig. 1 J-L). Intracellular cytokine 124 
staining of MLN CD4+ T cell populations showed no significant difference in 125 
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expression of IL-4 (Fig. 1 M), IL-5 (Fig. 1 N) or IL-13 (Fig. 1 O) between 126 
H.polygyrus-infected BALB/c and Il17rb–/– mice.  127 
Effective clearance of adult worms requires IL-25R within the hematopoietic 128 
immune compartment. 129 
During inflammation, expression of IL-25R has also been reported on antigen 130 
presenting cells (Gratchev et al., 2004), memory T cells (Wang et al., 2007), 131 
eosinophils (Tang et al., 2014) and human vascular endothelial cells (Wang et al., 132 
2012) as well as human fibroblasts (Gregory, et al., 2013). In addition, intestinal 133 
smooth muscle hypercontractility is compromised in IL-25-deficient helminth-infected 134 
mice (Pei, et al., 2016). Thus non-hematopoietic or hematopoietic cell expression of 135 
IL-25R might contribute to parasite expulsion in BALB/c mice. To assess this 136 
possibility, bone marrow chimeras were generated, infected with H. polygyrus and 137 
analysed 28 days later for egg and worm burden. Control chimeras reflected the 138 
phenotypes of intact mice as Il17rb–/– reconstituted with Il17rb–/– bone-marrow had 139 
significantly higher worm burdens than BALB/c reconstituted with BALB/c bone-140 
marrow (Fig. 2 A). Efficient adult worm expulsion and decreased egg burden were 141 
evident in mice lacking IL-25R on the non-hematopoietic compartment (Il17rb–/– 142 
reconstituted with BALB/c bone-marrow), however, delayed worm expulsion and 143 
increased egg burden occurred in mice lacking IL-25R within the hematopoietic 144 
immune compartment (Fig. 2 A, B).  145 
Effective clearance of adult worms in immune-deficient mice requires IL-25R and 146 
IL-4Rα signaling through the innate immune compartment 147 
To test whether stimulation of IL-25R within the innate immune compartment 148 
mediates adult worm expulsion and whether this is enhanced following IL-4Rα 149 
signaling, immune-deficient Rag1-/- mice were infected with H. polygyrus and injected 150 
with recombinant IL-25 late in infection (d14-17) and/or a complex of rIL-4:anti-IL-4 151 
(IL-4C) on days 13, 16 and 19 post-infection (Fig. 3 A). IL-4C exerted significant but 152 
modest reductions in egg counts (44%) and adult worm burden (34%) in Rag1-/- mice 153 
but did not completely expel adult worms or eliminate egg production (Fig. 3 B, C). 154 
Administration of IL-25 alone to Rag1-/- mice elicited a downward trend in adult worm 155 
numbers, which did not attain statistical significance in two experimental repeats. 156 
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However when both cytokines were combined, egg production was reduced by 95% 157 
and the adult worm burden also greatly reduced (by 87%). 158 
ILC2s may have a role in promoting acquired type-2 immune responses by activation 159 
of CD4+ T cell responses through expression of OX40L, MHC class II and PD-L1 160 
(Drake et al., 2014, Mirchandani et al., 2014, Oliphant et al., 2014, Schwartz et al., 161 
2017) or by promoting dendritic cell migration to draining lymph nodes following IL-162 
13 production (Halim et al., 2014). Sustained activation of ILCs drives immunity to N. 163 
brasiliensis infection (Bouchery et al., 2015), however in H. polygyrus infection the 164 
transfer of activated ILC2s had only a limited effect on worm establishment (Pelly et 165 
al., 2017). In addition, IL-25 is able to induce type-2 inflammation and goblet cell 166 
hyperplasia in the small intestine, independently of ILCs (Saenz, et al., 2013). To test 167 
whether ILCs contribute to efficient worm expulsion in immune-compromised mice 168 
following co-administration of IL-25 and IL-4C, we treated H. polygyrus infected 169 
Rag1-/- mice with both cytokines and isotype or anti-CD90.2 (Thy1.2) antibodies. 170 
Administration of anti-CD90.2 antibody significantly reduced the number of 171 
CD45+Lin- ILCs (Fig. 3 D, E) as well as the number of CD45+Lin-ST2- and CD45+Lin-172 
ST2+ ILCs (Fig. 3 F, G) in the PL of H. polygyrus-infected Rag1-/- mice treated with 173 
IL-25 and IL-4C. However, immunity was fully intact in recipients of this antibody, 174 
with significantly decreased parasite egg and worm burden in ILC-depleted mice (Fig. 175 
3 H, I).  176 
Stimulation of IL-25R induces adult worm clearance late, but not early, in 177 
infection 178 
The late manifestation of the Il17rb–/– phenotype in H. polygyrus infection could 179 
reflect a requirement either for initial IL-25 to generate an effector response that is 180 
only active after day 14, or for a later IL-25R-driven pathway that is invoked once the 181 
Th2 response is generated. To evaluate the relative importance of IL-25R engagement 182 
during different phases of infection, we made use of the more susceptible C57BL/6 183 
strain and delivered exogenous rIL-25 early (day 1-4) and late (day 14-17) post-184 
infection (Fig. 4 A). Egg counts were equivalent at day 14 post-infection before 185 
delivery of IL-25 late (Fig. 4 B) and were significantly reduced in recipients of IL-25 186 
early (66%; p=0.0013) or late (64%; p=0.0071) compared to PBS controls by day 28 187 
post-infection (Fig. 4 C). Although early IL-25 administration also induced a modest 188 
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reduction in adult worm burdens, this did not reach significance in two repeated 189 
experiments. In contrast, adult worm burden was significantly reduced in recipients of 190 
IL-25 late (66%; p=0.0016) at day 28 post-infection (Fig. 4 D). Both CD4+ T cell IL-4 191 
and IL-13 responses (Fig. 4 E-F), and the total number of ILCs (Fig. 4 G) were not 192 
significantly altered by late IL-25 injection. The number of IL-13+ILCs (ILC2s) was 193 
not significantly increased in the MLN at day 18 H. polygyrus infection but was 194 
significantly increased in infected mice following the administration of IL-25 (Fig. 4 195 
H), however, these remained a small proportion of the total ILCs within the MLN 196 
Monocytes and eosinophils require IL-25R and IL-4Rα signaling for a maximal 197 
type-2 response. 198 
Monocytes are important regulators of wound repair following Th2 inflammation and 199 
are activated to proliferate within the tissue site in response to IL-4Rα signaling, as 200 
confirmed in H. polygyrus-infected mice (Jenkins et al., 2013). These cells also 201 
respond to the alarmins IL-25 and IL-33 to promote type-2 cytokine production and 202 
alternative activation, where adoptive transfer of IL-33-activated macrophages has 203 
been reported to induce worm expulsion in mice with chronic H. polygyrus infection 204 
(Yang et al., 2013). Eosinophils also respond to IL-25 and are thought to play a role in 205 
limiting Th2 responses following H. polygyrus infection (Strandmark et al., 2017).  206 
Analysis of the peritoneal lavage revealed striking changes within macrophage and 207 
eosinophil populations following administration of IL-25 to H. polygyrus infected 208 
mice. IL-25 injection significantly increased production of IL-13 by Siglec-209 
F+CD11b+F4/80+ monocyte populations following administration of IL-25 to naïve and 210 
H. polygyrus infected mice (Fig. 5 A, B). Administration of IL-25 also significantly 211 
increased expression of the marker of alternative activation RELM-α by naïve 212 
macrophages in vivo (in an environment with low IL-4/13 levels), however alternative 213 
activation was further increased above and beyond this level in the setting of H. 214 
polygyrus infection (Fig. 5 B, C). A similar pattern was seen for the number of 215 
eosinophils in the PL (Fig. 5 D, E). The number of peritoneal monocytes was also 216 
significantly increased in response to IL-25, similar to the setting of H. polygyrus 217 
infection and a combination of infection and IL-25 (Fig. 5 F). In vitro treatment of 218 
bone-marrow-derived macrophages with recombinant cytokines confirmed previous 219 
reports that IL-4, but not IL-25, induced expression of the alternatively activated 220 
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macrophage marker RELM-α (Rizzo et al., 2012). However, when combined in vitro, 221 
we found a very marked synergy between IL-4 and IL-25 for increased macrophage 222 
RELM-α  (Fig. 5 G, H), as well as Arginase-1 expression (Fig. 5 I, J); in each case far 223 
above that observed for either cytokine alone.  224 
IL-25R co-operates with IL-4Rα signaling to prime innate immunity for effective 225 
clearance of H. polygyrus. 226 
It has long been known that IL-4Rα-mediated signaling is the pivotal component of the 227 
protective immune response to helminth infection, being required to generate the 228 
appropriate innate and adaptive type 2 cellular responses. To test whether IL-25-229 
mediated promotion of immunity to primary H. polygyrus infection was entirely 230 
dependent upon IL-4Rα, or could mediate an IL-4Rα-independent mode of protection, 231 
we administered exogenous IL-25 from days 14-17 of infection to Il4ra-deficient mice 232 
(Fig. 6 A). Although late IL-25 injection was previously demonstrated to induce adult 233 
worm expulsion in C57BL/6 mice (Fig. 4 D), the worm burden of Il4ra-/- mice was 234 
unaffected by administration of IL-25 at this time-point (Fig. 6 B). In a similar manner 235 
to C57BL/6 mice (Fig 5 C and D) IL-25 injection significantly increased the 236 
percentage of eosinophils in the PL of H. polygyrus infected BALB/c mice by day 18 237 
(Fig. 6 C). Within the BALB/c strain, 100% of macrophages within the PL expressed 238 
RELM-α+ by day 18 in H. polygyrus infected mice following administration of IL-25 239 
or PBS control, compared to an average of 28% in naïve mice (Fig. 6 D). However, 240 
these responses were completely lacking in infected Il4ra–/– mice treated with IL-25 241 
(Fig. 6 C, D), confirming that the IL-25 induced response is itself wholly dependent on 242 
IL-4Rα signaling.  243 
  244 
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Discussion 245 
Generation of the Type 2 immune response, and protection from helminth parasite 246 
infection, requires sustained interaction and participation of both innate and adaptive 247 
immune cells (Allen and Maizels, 2011, Grencis, 2015, Harris and Loke, 2017, Van 248 
Dyken et al., 2016). Alarmins such as IL-25 are potent activators of Type 2 immunity, 249 
but as we report here, can play an even more important role in stimulating and 250 
mobilising effector mechanisms to expel infection. Specifically, we show that adaptive 251 
type 2 responses develop normally in the absence of IL-25R but that eosinophil and 252 
macrophage responses are impaired, which is likely to explain compromised helminth 253 
expulsion in IL25R-deficient mice.  254 
Notably, by day 28 of H. polygyrus infection, the Il17rb–/– genotype was unable to 255 
reduce adult worm or egg burdens, despite the expression of comparable adaptive Th2 256 
response features such as IL-4 and IL-13 expression in CD4+ T cells. A requirement 257 
for IL-25/IL-25R signaling to expel H. polygyrus has previously been reported in other 258 
settings in which Th2 response levels appear unaffected, including both a vaccination 259 
model (Hewitson, et al., 2015), and following drug-abbreviated primary infection (Pei, 260 
et al., 2016). Similarly, it has been reported that the resolution of acute N. brasiliensis 261 
infection is delayed in Il25–/– mice despite sufficient Th2 cell differentiation (Mearns, 262 
et al., 2014). These results therefore suggest that Th2 differentiation can occur 263 
independently of IL-25R signaling following helminth infection and reinforce the idea 264 
that innate type-2 responses can operate autonomously from adaptive type-2 responses 265 
to control parasite expulsion (Smith et al., 2012). 266 
A wide range of cell types respond to IL-25, but we demonstrated by chimera 267 
experiments that parasite expulsion requires receptor expression on haematopoietic, 268 
rather than non-haematopoietic cells in vivo. As adaptive Th2 responses were 269 
comparable in IL-25-deficient and sufficient infected mice, we examined innate 270 
populations. In N. brasiliensis infections, intestinal tuft cell-derived IL-25 drives 271 
parasite expulsion and the activation of ILC2s in a positive feedback loop mediated by 272 
IL-13 (Gerbe, et al., 2016, von Moltke, et al., 2016). However, our data indicate that 273 
innate lymphoid cells may not be required for immunity to H. polygyrus, because anti-274 
CD90 (Thy1) antibody depletion of these cells from Rag1-deficient mice did not affect 275 
the ability of IL-25 (in combination with IL-4Rα signaling) to expel H. polygyrus 276 
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parasites. Through the use of ST2 staining we were able to demonstrate that both the 277 
resident Lin-ST2+CD90hi, and the inflammatory Lin-ST2-CD90low ILC populations 278 
recently described (Huang, et al., 2015) are depleted following administration of anti-279 
CD90.2 antibody to H. polygyrus-infected mice given IL-25.  It is possible that our 280 
regime of anti-CD90.2 antibody treatment spares a residual and essential ILC 281 
population, but genetic strategies to fully ablate ILCs by deletion of the common 282 
gamma chain receptor (ΰc) are confounded in our system because ΰc also forms part of 283 
the IL-4R.  284 
It has previously been noted that ILC2 numbers show only modest expansion in the 285 
MLN of C57BL/6 mice infected with H. polygyrus and that these can be considerably 286 
boosted following administration of IL-25 (Hepworth et al., 2012). In confirming this, 287 
our data also show an increase in total ILCs with H. polygyrus infection, of which only 288 
a small proportion are ILC2s. One explanation is that chronic H. polygyrus infection 289 
limits IL-25 and ILC2 expansion by eliciting the production of IL-1ί (Zaiss et al., 290 
2013). We have also demonstrated that H. polygyrus infection results in the 291 
preferential trafficking of LTi-like ILC3s to the MLN (Mackley et al., 2015), pointing 292 
again to a diminished role of ILC2s in immunity to this infection., while a recent study 293 
reported only modest reduction in adult H. polygyrus worm burdens in mice in whom 294 
ILC2 numbers were expanded fivefold with IL-2:anti-IL-2 complex (Pelly, et al., 295 
2017). 296 
In contrast, we uncover striking IL-25R-dependent modifications to macrophage and 297 
eosinophil populations following H. polygyrus infection, in two important respects. 298 
Firstly, the expansion of eosinophil and alternatively activated macrophage numbers 299 
seen following helminth infection is strikingly amplified by IL-25. Secondly, IL-25 300 
was required for the expression of IL-13 within macrophages, in accordance with 301 
earlier publications (Fort, et al., 2001, Yang, et al., 2013). Macrophages may thus 302 
represent a major source of IL-13 in infected animals, suggesting an element of 303 
autologous stimulation through the IL-13-responsive IL-4Rα, which is required for 304 
macrophage alternative activation.  305 
The alternative activation of macrophages is critical for immunity to H. polygyrus 306 
(Anthony et al., 2006), and we now show that IL-25, in addition to IL-4Rα signaling, is 307 
required both for optimal macrophage activation, and for parasite elimination. Thus, 308 
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for example, the two cytokines synergise dramatically to induce high levels of RELM-309 
α. Consistent with established findings, macrophage activation by IL-25 cannot occur 310 
in the absence of IL-4Rα signaling (Kang et al., 2012). Interestingly, the production of 311 
IL-25 following nematode infection is itself dependent on IL-4Rα, mediated by IL-13 312 
activation of STAT6 (Zhao, et al., 2010). Furthermore, upregulation of the IL-25 313 
receptor Il17rb in the small intestine is STAT-6 dependent (Zhao, et al., 2010). We are 314 
currently investigating whether macrophage expression of the IL-25 receptor is 315 
specifically required for parasite expulsion in the presence of IL-4Rα signaling.  316 
In summary, we demonstrate that the IL-25R is not required for generation of a 317 
sufficient Th2 response to helminth infection and that instead, it is required for late 318 
effector responses to fully resolve chronic infection. We identify the macrophage and 319 
the eosinophil as two prominent populations activated following IL-25 administration, 320 
with induction of IL-13 expression within macrophages that is likely, in turn, to drive 321 
the suite of intestinal epithelial mechanisms that lead to nematode expulsion (Cliffe et 322 
al., 2005, Maizels et al., 2012, Patel, et al., 2009). We also clearly demonstrate an 323 
enhancement in macrophage alternative activation, which plays a critical role in 324 
nematode immobilisation and killing (Hewitson, et al., 2015) and suggest that ILC2s 325 
may be redundant in driving IL-25R-dependent immunity to chronic helminth 326 
infection. These results now place IL-25 in the central role of mobilising innate 327 
effector cells other than ILCs, in the context of an IL-4/13-replete environment, to 328 
protect against chronic gastrointestinal helminth infection. Future work will elucidate 329 
in greater detail the range of responsive cells and their inter-relationship in the network 330 
that orchestrates parasite expulsion and immunity.  331 
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Materials and Methods 332 
Key Resources Table 333 
Reagent type 
(species) or resource 
Designation Source or reference Identifiers 
Mus musculus, 
BALB/c 
Il17rb
-/-
 (IL-25R
-/-
) 
Neill DR, et al  (2010) Nuocytes 
represent a new innate effector 
leukocyte that mediates type-2 
immunity. Nature 464:1367-1370 
  
Mus musculus, 
C57BL/6 
Rag1
-/-
 
Mombaerts,P., Iacomini,J., 
Johnson, R.S., Herrup, K., 
Tonegawa,S., and Papaioannou, 
V. E. 1992. Cell. Vol 68: 869-877. 
PMID: 1547488 
  
Mus musculus, 
C57BL/6 
Il4ra-/- 
Noben-Trauth N, Shultz LD, 
Brombacher F, Urban JF, Jr., Gu 
H, Paul WE. 1997. An interleukin 
4 (IL-4)-independent pathway for 
CD4+ T cell IL-4 production is 
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Parasite 
Heligmosomoides 
polygyrus bakeri 
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antibody Anti-IL-4 BioXCell Clone 11B11 
antibody Anti-IL-13 BioLegend JES10-5A2 
antibody Anti-CD90.2 BioXCell 30H12 
antibody Anti-SiglecF  BD Pharmingen E50-2440 
antibody Anti-CD11b  BioLegend M1/70 
antibody Anti-F4/80  BioLegend BM8 
antibody Anti-Ly6G BioLegend 1A8 
antibody Anti-Ly6C BioLegend AL-21 
antibody Anti-RELMα R&D Systems 22603 
antibody 
Anti-Arginase-1 
(Polyclonal) 
R&D Systems IC5868P 
antibody Anti-Lineage BioLegend 
17A2,RB6-
8C5,RA3-
6B2,Ter-
119,M1/70 
peptide, recombinant IL-4 Peprotech 214-14 
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protein 
peptide, recombinant 
protein 
IL-25 BioLegend 587302 
commercial assay or 
kit 
Foxp3 Staining Kit eBioScience 88-8118 
other 
Control IgG2b 
immunoglobulin 
BioXcell LTF-2 
other 
Anti-CD90.2 
Microbeads 
Miltenyi 130-049-101 
 334 
Mice 335 
BALB/c, IL-25R–/– (Il17rb–/–) (Neill, et al., 2010), C57BL/6, Rag1-/- mice and Il4ra-/- 336 
mice were bred at the University of Edinburgh. All animal protocols adhered to the 337 
guidelines of the UK home office, complied with the Animals (Scientific Procedures) 338 
Act 1986, were approved by the Ethical Review Committees of the University of 339 
Edinburgh and the University of Glasgow, and were performed under the authority of 340 
the UK Home Office Project numbers 60/4105 and 70/8384. 341 
Construction of bone marrow chimeras 342 
BALB/c or Il17rb–/– mice were exposed to 11.5 Gy ΰ radiation administered in two 343 
doses before intravenous reconstitution with 2 million bone marrow cells from 344 
BALB/c or Il17rb–/– mice, which had been depleted of CD90+ cells using CD90.2 345 
microbeads (Miltenyi). Eight weeks post-transfer, recipients were infected with 200 H. 346 
polygyrus by gavage. 347 
Parasites and Antigens 348 
H. polygyrus bakeri was maintained and adult H. polygyrus HES was prepared as 349 
described elsewhere (Grainger et al., 2010, Johnston et al., 2015). Egg counts from 350 
individual mice were assessed by weighing the feces before dissolving in 2 ml 351 
saturated sodium chloride solution; egg counts were performed using a McMaster 352 
chamber and the average number of eggs/g feces calculated per sample. Mice were 353 
infected with 200 L3 stage H. polygyrus by gavage. 354 
Preparation and administration of IL-4/anti-IL-4 complexes 355 
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A pre-prepared complex of 5μg rIL-4 (Peprotech) and β5μg anti-IL-4 (clone 11B11; 356 
BioXcell, NH) was administered to mice i.p. (Urban et al., 1995). 357 
Depletion of ILCs 358 
Rag1-/- mice received β00μg anti-CD90.2/Thy1.2 (clone 30H12; BioXcell) or a rat 359 
IgG2b control (clone LTF-2; BioXcell) i.p. on days 12, 15, 18 and 21 post-infection.  360 
In vitro Ag-specific restimulation 361 
A single cell suspension was made of MLN before plating cells at 5x105/well in the 362 
presence of βμg/ml HES and media alone for 7β h at γ7°C/5% CO2. Supernatants were 363 
then harvested and analysed for IL-4, IL-5, IL-13 by commercially available ELISA 364 
(BD Pharmingen). 365 
Generation of bone marrow-derived macrophages 366 
Bone marrow was extracted from tibia and femurs of C57BL/6 mice. A single cell 367 
suspension was formed in 10ml of PBS by passing through a 23g needle, then filtered 368 
through a 100µm nylon cell strainer. Cells were plated at a density of 6 x 106 cells/ 369 
plate on 90 cm Petri dishes in 10 ml cDMEM with 20% L929 media as a source of M-370 
CSF and incubated at 37°C incubator with 5% CO2. A further 5 ml of cDMEM with 371 
20% L929 was added on day 3. Differentiated macrophages were harvested on day 7 372 
using 3 mM EDTA/10 mM glucose in PBS. Cells were washed in PBS, resuspended in 373 
cDMEM, plated at 2 x 105 cells/ well in 96 well plates and stimulated with 10ng/ml IL-374 
4, 200ng/ml IL-25 or a combination of both for 16 hours before analysis of the cells by 375 
flow cytometry.  376 
 377 
Flow Cytometry 378 
All flow cytometry was performed using Becton-Dickinson Canto or LSR-II flow 379 
cytometers. For innate cell surface phenotyping, PL or MLN were stained with a 380 
combination of antibodies to Siglec-F (E50-2440), CD11b (M1/70), F4/80 (BM8), 381 
Ly6G (1A8) and Ly6C (AL-21 or HK1.4). Following fixation and permeabilisation 382 
with the Foxp3 staining kit (eBioscience) cells underwent intracellular staining with 383 
RELM-α (RnD Systems) followed by zenon anti-rabbit A647 (Invitrogen) and FITC-384 
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conjugated anti-human Ki67 (BD Biosciences). For intracellular cytokine staining of 385 
monocytes, 0.5-1x106 PL cells were incubated with 10μg/ml Brefeldin A for 4 hours. 386 
Following cell surface staining as above, and fixation and permeabilization with 387 
Fix/Perm buffer (BD Pharmingen), cells underwent intracellular staining with anti-IL-388 
13 (JES10-5A2). For intracellular staining of lymphocytes, MLNCs were incubated 389 
with 0.5μg/ml PMA and 1μg/ml ionomycin for 1 h before the addition of 10μgml 390 
Brefeldin A for a further 3 h. Staining was performed by re-suspending cells in a 391 
combination of Abs to CD4 (GK1.5), ICOS (DX29), and the following combination to 392 
define Lin–: CD3 (17A2), CD5 (53-7.3), CD8α (RPA-T8), CD49b (DX5), CD11c 393 
(HL3), F4/80 (BM8), CD19 (eBio1D3), Gr-1 (RB6-8C5), TCRί (H57-597) and 394 
CD11b (M1/70). 395 
Statistical analysis 396 
Data were assessed for normality and equal variance and were log transformed if 397 
required; all data passed these criteria and an unpaired t test was used or, where more 398 
that three groups were tested, a parametric one-way ANOVA followed by Tukey’s 399 
multiple comparison test was used. 400 
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Figure Legends 678 
Figure 1  679 
IL-25R signaling is required for expulsion of H. polygyrus from BALB/c mice 680 
H. polygyrus-infected BALB/c or Il17rb-deficient (IL25R–/–) BALB/c mice were 681 
analyzed at day 14 post-infection for fecal egg counts (A) and intestinal adult worm 682 
burden (B) or day 28 post-infection for fecal egg counts (C) and intestinal adult worm 683 
burden (D). MLN underwent intracellular cytokine staining (ICCS) to compare the 684 
number of Lin-ICOS+ innate lymphoid cells (ILCs) (E) and IL-13+ ILC2s (F) by flow 685 
cytometry in the different naïve and day 14 infected genotypes. Peritoneal lavage cells 686 
(PL) were stained with Siglec-F, CD11b and Ly6G/C to compare the number of 687 
Siglec-F-CD11b+Ly6G/C+ monocytes (G) in the different naïve and day 14 infected 688 
genotypes. Percentages of eosinophils (H) and RELMα+ alternatively-activated 689 
macrophages (Ι) were also determined over a 4-week infection timecourse. ELISA of 690 
supernatants from MLN incubated with media or 1μg HES for 72 h was performed to 691 
compare IL-4 (J), IL-5 (K) and IL-13 (L) production in the different naïve and day 14 692 
infected genotypes. ICCS of MLN allowed a comparison of the proportion of IL-4+, 693 
IL-5+ and IL-13+ CD4+ T cells by flow cytometry in the different naïve and day 14 694 
infected genotypes (M-O). Results shown are one representative of 3 experiments with 695 
n≥4 mice/group (A-D), pooled data from β experiments with n≥4 mice/group (C-F, M-696 
O) or one representative of β experiments with n≥4 mice/group (G-L). Data were 697 
analysed by unpaired t test or one way ANOVA, where * = p≤0.05,** = p≤0.01,*** = 698 
p≤0.001 and ns = not significant. Error bars represent Standard Error of the Mean. 699 
  700 
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Figure 2 701 
IL-25R signaling is required within the hematopoietic compartment for efficient 702 
expulsion 703 
Bone marrow chimeras generated from BALB/c (WT) or Il17rb-deficient (KO) donor 704 
and BALB/c (WT) or Il17rb-deficient (KO) recipient mice were infected with H. 705 
polygyrus and intestinal adult worm burden (A) and fecal egg burden (B) performed at 706 
day 28 post-infection. Results shown are pooled data from 2 experiments performed 707 
with n≥γ mice/group, and data from all individual mice are presented. Data were 708 
analysed by unpaired t test, where * = p≤0.05,** = p≤0.01,*** = p≤0.001 and ns = not 709 
significant. Error bars represent Standard Error of the Mean. 710 
 711 
 712 
Figure 3 713 
IL-25R signaling synergises with IL-4Rα within the innate immune compartment 714 
to facilitate efficient worm expulsion. 715 
H. polygyrus infected Rag1-/- mice (RAG-/-)  were given 0.4 µg recombinant IL-25 i.p. 716 
days 14-17 (late) post-infection with or without a complex of 5 μg rIL-4 and β5 μg 717 
anti-IL-4 (IL-4C) on days 13, 16 and 19 post-infection, according the schedule shown 718 
in (A). Mice were analyzed at 28 days post-infection for fecal egg burden (B) and 719 
intestinal adult worm burden (C). H. polygyrus-infected Rag1-/- mice were given IL-25 720 
and IL-4C according to the same schedule, as well as 200 µg of anti-CD90.2/Th1.2 721 
antibody or rat IgG2b control (days 12, 15, 18 and 21). The peritoneal lavage was 722 
analyzed at 28 days post-infection for CD45+lin- (CDγ, CD5, CD8α, CD11c, CD19, 723 
DX5, F4/80, GR-1, TCRί, CD11b), ICOS and STβ staining by flow cytometry as 724 
shown (D) and the number of CD45+lin– (E), CD45+lin–ST2– (F) and CD45+lin–ST2+ 725 
(G) ILCs was determined. Mice were analysed at 28 days post-infection for fecal egg 726 
burden (H) and intestinal adult worm burden (I). Results shown are one representative 727 
of 2 experiments with n=4 mice/group (D-G), or pooled data from 2 experiments with 728 
n≥γ mice/group (B,C,H,I). Data were analysed by unpaired t test, where * = p≤0.05,** 729 
= p≤0.01,*** = p≤0.001 and ns = not significant. Error bars represent Standard Error 730 
of the Mean. 731 
 732 
 733 
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Figure 4 735 
IL-25 induces protective immune responses in the late stage of infection 736 
H. polygyrus infected C57BL/6 mice were given 0.4 μg recombinant IL-25 i.p. at day 737 
1-4 (early) or day 14-17 (late) post-infection according to the schedule shown in (A). 738 
Before administration of IL-25, intestinal egg burden was analysed in two groups at 739 
day 14 post-infection (B). Mice were then analysed at day 28 post-infection for fecal 740 
egg counts (C) and intestinal adult worm burden (D) following administration of IL-25 741 
early or late. H. polygyrus infected C57BL/6 mice were given 0.4μg recombinant IL-742 
25 i.p. at day 14-17 (late) post-infection. Day 18 post-infection, MLN underwent ICCS 743 
to compare the proportion of IL-4+CD4+ (E) and IL-13+CD4+ (F) T cells, as well as the 744 
number of ILCs (G) and Lin-IL-13+ ILC2s (H) by flow cytometry. Results shown are 745 
data pooled from γ experiments with n≥γ mice/group (B-D), or are representative of 2 746 
experiments with n=4 mice/group (E,F) or pooled from 2 experiments with n=4 747 
mice/group (G, H). Data were analysed by unpaired t test, where * = p≤0.05,** = 748 
p≤0.01,*** = p≤0.001 and ns = not significant. Error bars represent Standard Error of 749 
the Mean. 750 
 751 
Figure 5 752 
IL-25 drives alternative activation and IL-13 expression of macrophages 753 
H. polygyrus infected C57BL/6 mice were given 0.4 μg recombinant IL-25 i.p. at day 754 
14-17 (late) post-infection. At day 18 post-infection, PL cells were taken and 755 
stimulated with 10μg Brefeldin A to determine the expression intensity (geomean) of 756 
IL-13 (A) or were unstimulated to determine the expression intensity (geomean) of 757 
RELM-α (B, C) within Siglec-F–CD11b+F4/80+ monocytes by flow cytometry, as 758 
shown by the example flow cytometry plots in B and compared to fluorescence minus 759 
one (FMO) samples stained from the Hp:IL-25 group. Total Siglec-F+CD11b+ 760 
eosinophil (D) numbers were calculated from populations shown in the example flow 761 
cytometry plots (E), numbers of Siglec-F–CD11b+ (F) monocytes. Bone marrow-762 
derived macrophages from C57BL/6 mice were generated in vitro and stimulated with 763 
10 ng/ml IL-4, 200 ng/ml IL-25 or a combination of both for 16 hours before analysis 764 
of the percentage of RELM-α expression (G, H) and the mean fluorescence intensity 765 
(geometric mean) of Arginase-1 expression (I, J) within CD11b+F4/80+ cells by flow 766 
cytometry. Results shown are one representative of 2 experiments with n=4 mice/group 767 
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(A-F, I, J) or pooled from 2 experiments with n=4 replicates/group (G, H). Data were 768 
analysed by unpaired t test, where * = p≤0.05,** = p≤0.01,*** = p≤0.001 and ns = not 769 
significant. Error bars represent Standard Error of the Mean. 770 
 771 
Figure 6 772 
IL-4Rα expression is required for activation of the immune system by IL-25. 773 
H. polygyrus infected Il4ra-/- mice (IL-4R-/-) were given 0.4 μg recombinant IL-25 i.p. 774 
days 14-17 (late) post-infection (A). Mice were analyzed at day 28 post-infection for 775 
intestinal adult worm burden (B). H. polygyrus infected BALB/c and Il4ra-/- mice (IL-776 
4R-/-) were given 0.4 μg recombinant IL-25 i.p. days 14-17 (late) post-infection. Day 777 
18 post-infection, PL cells were taken to determine the percentage of eosinophils (C) 778 
and percentage of RELM-α expression within Siglec-F-CD11b+F4/80+ macrophages by 779 
flow cytometry (D). Results shown are one representative of β experiments with n≥4 780 
mice/group (A-D). Data were analysed by unpaired t test, where * = p≤0.05,** = 781 
p≤0.01,*** = p≤0.001 and ns = not significant. Error bars represent Standard Error of 782 
the Mean. 783 
 784 
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